Meet us at JP Morgan Healthcare Conference on Jan 7-10 in San Francisco. We have a lot of exciting updates!

by nobilistx | Dec 20, 2018 | Uncategorized |

US Patent Granted for Nobilis Therapeutics Invention Covering Treatments of Rheumatologic Disorders With Noble Gases

by nobilistx | Aug 1, 2018 | Uncategorized |

PORTLAND, Ore., August 1, 2018 (Newswire.com) – Nobilis Therapeutics announced today the issuance of the United States patent filed by the company in June of 2017. The patent number 10,022,397, titled “TREATMENT OF RHEUMATOID ARTHRITIS USING NOBLE GAS MIXTURES”...

Nobilis Therapeutics Adds Three World-Renowned PTSD Experts to Scientific Advisory Board

by nobilistx | Jun 1, 2018 | Uncategorized |

Nobilis Therapeutics Adds Three World-renowned PTSD Experts to Scientific Advisory Board PORTLAND, OR–(Newswire.com – June 1, 2018) – Nobilis Therapeutics, today announced addition of Dr. Paula Schnurr, Dr. Barbara Rothbaum and Dr. Israel Liberzon to...

Nobilis Therapeutics will participate in BIO International Convention in Boston, MA on June 4-7, 2018

by nobilistx | May 18, 2018 | Uncategorized |

We are happy to announce that Nobilis Therapeutics team will attend BIO International Convention that will take place on June 4-7 in Boston, MA. We look forward to discussing the progress that the company has made in the last several months and welcome invitations to...

Nobilis Therapeutics issues a press release after a productive meeting with the House of Representatives Committee on Veterans’ Affairs.

by nobilistx | Feb 23, 2018 | Uncategorized |

Nobilis Therapeutics Presents Its PTSD Clinical Development Program To The US Congress WASHINGTON, Feb. 23, 2018 (GLOBE NEWSWIRE) — Dr. Edward Meloni, PhD of McLean Hospital (Harvard Medical School Affiliate) and Dr. Vlad Bogin, CEO and Founder of Nobilis...